Bradley Foster & Sargent Inc/Ct / ABT
Bradley Foster & Sargent Inc/Ct’s Abbott Laboratories Position
Does Bradley Foster & Sargent Inc/Ct own Abbott Laboratories (ABT)? Yes — 611.0K shares worth $63M (+0.97% of its 13F portfolio) as of Q1 2026, down from 834.9K shares the prior filed quarter.
Position Value
$63M
Q1 2026
Shares
611.0K
% of Portfolio
+0.97%
Quarters Held
28
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 611.0K | $63M | +0.97% |
| Q4 2025 | 834.9K | $105M | +1.54% |
| Q3 2025 | 830.8K | $111M | +1.64% |
| Q2 2025 | 829.3K | $113M | +1.77% |
| Q1 2025 | 777.7K | $103M | +1.76% |
| Q4 2024 | 635.8K | $72M | +1.21% |
| Q3 2024 | 600.3K | $68M | +1.14% |
| Q2 2024 | 508.8K | $53M | +0.95% |
| Q1 2024 | 465.0K | $53M | +0.95% |
| Q4 2023 | 452.5K | $50M | +0.97% |
| Q3 2023 | 424.1K | $46M | +0.97% |
| Q2 2023 | 424.1K | $46M | +0.97% |
| Q1 2023 | 346.8K | $35M | +0.84% |
| Q4 2022 | 347.5K | $38M | +0.96% |
| Q3 2022 | 345.1K | $33M | +0.92% |
| Q2 2022 | 346.8K | $38M | +0.97% |
| Q1 2022 | 350.0K | $41M | +0.88% |
| Q3 2021 | 330.6K | $39M | +0.92% |
| Q2 2021 | 337.7K | $39M | +0.92% |
| Q1 2021 | 340.3K | $41M | +1.03% |
| Q4 2020 | 352.9K | $39M | +1.02% |
| Q3 2020 | 353.1K | $38M | +1.13% |
| Q1 2020 | 362.0K | $29M | +1.14% |
| Q4 2019 | 364.5K | $32M | +0.98% |
| Q3 2019 | 366.8K | $31M | +1.02% |
| Q2 2019 | 370.7K | $31M | +1.03% |
| Q1 2019 | 377.1K | $30M | +1.05% |
| Q4 2018 | 381.4K | $28M | +1.11% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bradley Foster & Sargent Inc/Ct’s full portfolio or all institutional holders of ABT.